More insight into what went wrong when the Emergent BioSolutions, Inc. Bayview plant in Baltimore ramped up for COVID-19 vaccine drug substance manufacturing emerged during a 19 May US congressional hearing.
And there were glimmers at the House Select Subcommittee on the Coronavirus Crisis hearing of the lessons that must be...